Psychiatry and Neurology, Neurology · Tuscaloosa, AL
NPI
1437253044
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
100 Rice Mine Road Loop Ste 301
Tuscaloosa, AL, 35406
Phone (205) 345-3881
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
8,199 services
Medicare patients, 2024
418
Average age 72
Drug cost, 2024
$2.4M
5,913 prescriptions
Company payments, 2025
$2,990
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arturo Otero was code J0585 (injection, onabotulinumtoxina, 1 unit), 6,500 times for 11 patients. In total Arturo Otero billed 8,199 services in 34 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 6,500 | 11 | $3.93 | $26K |
| 99214 Office E&M - Established | Office | 479 | 297 | $78.68 | $38K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 229 | 182 | $11.49 | $2,632 |
| 95886 Electrical Nerve Conductivity | Office | 92 | 82 | $63.33 | $5,827 |
| 95913 Electrical Nerve Conductivity | Office | 46 | 44 | $193.53 | $8,903 |
| 95819 Neurologic | Office | 41 | 40 | $291.76 | $12K |
| 99205 Office E&M - New | Office | 41 | 41 | $125.94 | $5,163 |
| 99215 Office E&M - Established | Office | 38 | 36 | $116.46 | $4,425 |
| 95911 Electrical Nerve Conductivity | Office | 37 | 36 | $143.82 | $5,321 |
| 70551 MRI/MRA - Head and Neck | Office | 37 | 35 | $81.76 | $3,025 |
| 95910 Electrical Nerve Conductivity | Office | 33 | 33 | $117.74 | $3,885 |
| 95885 Electrical Nerve Conductivity | Office | 31 | 23 | $41.96 | $1,301 |
| 99204 Office E&M - New | Office | 31 | 31 | $117.48 | $3,642 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 17 | 17 | $108.29 | $1,841 |
By year: 2022 $139K for 5,146 services; 2023 $647K for 10,477 services; 2024 $193K for 8,199 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arturo Otero prescribed most often to Medicare patients was Gabapentin, with 574 prescriptions and refills. In total Arturo Otero wrote 5,913 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 574 | 685 | 109 | $7,249 |
| Levetiracetam Generic | 295 | 443 | 54 | $7,902 |
| Donepezil Hcl Generic | 261 | 393 | 71 | $1,837 |
| Topiramate Generic | 223 | 347 | 52 | $2,746 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 198 | 288 | 40 | $6,145 |
| Pregabalin Generic | 192 | 240 | 46 | $4,778 |
| Clonazepam Generic | 167 | 207 | 27 | $2,695 |
| Amitriptyline Hcl Generic | 163 | 225 | 33 | $4,033 |
| Ropinirole Hcl Generic | 144 | 180 | 24 | $3,130 |
| Tramadol Hcl Generic | 142 | 142 | 24 | $348 |
| Galantamine Er Galantamine Hbr | 140 | 197 | 34 | $13K |
| Memantine Hcl Generic | 136 | 209 | 33 | $5,684 |
| Lacosamide Generic | 134 | 160 | 18 | $7,411 |
| Divalproex Sodium Er Divalproex Sodium | 130 | 171 | 28 | $3,539 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 122 | 122 | 17 | $1,186 |
Brand drugs: 563 claims; generic drugs: 5,332 claims; opioid claims: 297.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Arturo Otero $2,990 ($2,990 in general payments such as food, travel and fees) from 36 companies. The largest payer was Abbvie Inc. with $592.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $592 |
| Pfizer Inc. PFE | 40 | $548 |
| Biogen, Inc. BIIB | 7 | $199 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $163 |
| Neurocrine BioSciences, Inc. NBIX | 7 | $147 |
| SK Life Science, Inc. | 4 | $127 |
| UCB, Inc. UCB.BR | 4 | $108 |
| Amgen Inc. AMGN | 5 | $96.2 |
| Janssen Biotech, Inc. JNJ | 3 | $79.26 |
| Genentech USA, Inc. ROG.SW | 3 | $73.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.